Generic name: tobramycin and fluorometholone acetate
Dosage form: ophthalmic suspension
Medically reviewed on September 21, 2017.
One or two drops instilled into the conjunctival sac(s) every four to six hours. During the initial 24 to 48 hours, the dosage may be increased to one or two drops every two (2) hours. Frequency should be decreased gradually as warranted by improvement in clinical signs. Care should be taken not to discontinue therapy prematurely.
Not more than 20 mL should be prescribed initially and the prescription should not be refilled without further evaluation as outlined in PRECAUTIONS above.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.